ARWR:NASDAQ
Arrowhead Pharmaceuticals Inc
$70.67
arrow_downward
-12.40%(-10.00) 1D
$71.82
arrow_upward
+1.63% (+1.15)bedtimeAfter hours
Closed: Sep 15, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARWR...
Open
$82.89
High
$83.55
Low
$70.60
Mkt. cap
9.98B
Avg. vol.
1.26M
Volume
4.37M
52-wk high
$95.49
52-wk low
$28.48
EPS
-$2.24
Beta
1.28
Shares outstanding
141.25M
No. of employees
711
Open
$82.89
High
$83.55
Low
$70.60
Mkt. cap
9.98B
Avg. vol.
1.26M
Volume
4.37M
52-wk high
$95.49
52-wk low
$28.48
EPS
-$2.24
Beta
1.28
Shares outstanding
141.25M
No. of employees
711
News stories
From web sources and news partners
Yahoo Finance
·
6 hours ago
ARWR Stock Heads For Worst Day In Over A Year Despite Positive Cholesterol Drug Data — Is This A ‘Sell The News’ Move?
Benzinga
·
8 hours ago
10-Year Yield Tops 5%, Oil Storms Past $105: Stock Market Today
TradingKey
·
9 hours ago
Arrowhead Pharmaceuticals Inc Stock (ARWR) Moved Down by 8.93% on Sep 15: What Investors Need To Know
GuruFocus
·
13 hours ago
ARWR Looks 59.6% Overvalued on GF Value™
Profile
Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead's products in development act through RNA interference mechanisms of action. The company focuses on treatments for hepatitis B, liver disease associated with alpha 1-antitrypsin deficiency and cardiovascular disease. Wikipedia
About Arrowhead Pharmaceuticals Inc
CEOChristopher Richard Anzalone
Employees711
FoundedJan 1, 2004
HeadquartersPasadena, California, United States
SectorBiotechnology
Websitearrowheadpharma.com